Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-02-20

Clinical Trial Update: Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry

View source ↗

Summary

A multicenter registry is evaluating the use of radiofrequency ablation for pancreatico-biliary disorders, including cholangiocarcinoma and pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Radiofrequency ablation (radiofrequency energy)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Cholangiocarcinoma, Pancreatic Cancer | Status: UNKNOWN